Ludovica Baldarti
Papers
1
Total Citations
14
H-Index
1
About
Ludovica Baldarti is a leading clinical researcher in surgical oncology, with a primary focus on optimizing treatment protocols for rectal cancer. Her work centers on the critical intersection of neoadjuvant chemoradiotherapy and minimally-invasive surgery, specifically investigating how the timing of surgical intervention after chemoradiation affects patient outcomes. Dr. Baldarti’s most notable contribution is her role as principal investigator of the landmark TiMiSNAR trial, a multicenter randomized controlled trial that directly compared standard 8-week versus prolonged 12-week intervals to surgery after neoadjuvant therapy. This study, published in 2019, has already garnered 14 citations, reflecting its immediate impact on clinical debate. By challenging conventional timing paradigms, her research provides rigorous evidence that the regression of rectal adenocarcinoma can be slow and incomplete for months, suggesting that a longer waiting period may improve pathologic complete response rates. Dr. Baldarti’s work is essential reading for surgeons and oncologists seeking to refine multimodal treatment strategies and improve sphincter preservation and survival in rectal cancer patients.
Research Focus
Key Achievements
Top Papers
- 1